Efficacy and Safety of the Genistein Nutraceutical Product Containing Vitamin E, Vitamin B3, and Ceramide on Skin Health in Postmenopausal Women: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- PMID: 36835861
- PMCID: PMC9963595
- DOI: 10.3390/jcm12041326
Efficacy and Safety of the Genistein Nutraceutical Product Containing Vitamin E, Vitamin B3, and Ceramide on Skin Health in Postmenopausal Women: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Abstract
Skin aging is one of the most concerning issues that occur after menopause. The Genistein Nutraceutical (GEN) product, containing genistein, vitamin E, vitamin B3, and ceramide, has been formulated as a topical anti-aging product for improving the health of postmenopausal women's facial skin. This study aimed to investigate the efficacy and safety of the GEN product on postmenopausal women's facial skin. This randomized, double-blind, placebo-controlled trial randomly assigned 50 postmenopausal women to receive either the GEN product (n = 25) or the placebo (PLA) product (n = 25), topically applied twice daily for 6 weeks. The outcome assessments included multiple skin parameters related to skin wrinkling, color, hydration, and facial skin quality at baseline and week 6. The percentage mean changes or absolute mean changes, where appropriate, in skin parameters were compared between the two groups. The mean age of the participants was 55.8 ± 3.4 years. For skin wrinkling and skin color parameters, only skin redness was significantly higher in the GEN group when compared to the PLA group. Following the application of the GEN product, skin hydration increased while fine pores and their area decreased. Subgroup analysis of older women (age ≥ 56 years) with adequate compliance found significant differences between the two groups in the percentage mean changes of most skin wrinkle parameters. The GEN product has benefits for the facial skin of postmenopausal women, particularly those who are older. It can moisturize facial skin, lessen wrinkles, and enhance redness.
Keywords: genistein; menopause; nutraceuticals; postmenopausal women; randomized-controlled trial; skin aging.
Conflict of interest statement
N.K., P.K., W.S., N.D., R.I., R.K. and W.C. declare no conflict of interest. Chiang Mai University, a public university, has submitted the petty patent application for the Genistein Nutraceutical product, with S.T. and M.N.T. listed as the inventors. S.T. is a shareholder of the company that distributes the Genistein Nutraceutical product in the market. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures



Similar articles
-
Does hormone therapy improve age-related skin changes in postmenopausal women? A randomized, double-blind, double-dummy, placebo-controlled multicenter study assessing the effects of norethindrone acetate and ethinyl estradiol in the improvement of mild to moderate age-related skin changes in postmenopausal women.J Am Acad Dermatol. 2008 Sep;59(3):397-404.e3. doi: 10.1016/j.jaad.2008.05.009. Epub 2008 Jul 14. J Am Acad Dermatol. 2008. PMID: 18625536 Clinical Trial.
-
Collagen concentration on the facial skin of postmenopausal women after topical treatment with estradiol and genistein: a randomized double-blind controlled trial.Gynecol Endocrinol. 2017 Nov;33(11):845-848. doi: 10.1080/09513590.2017.1320708. Epub 2017 May 16. Gynecol Endocrinol. 2017. PMID: 28508697 Clinical Trial.
-
Prospective Randomized Controlled Trial on the Effects of Almonds on Facial Wrinkles and Pigmentation.Nutrients. 2021 Feb 27;13(3):785. doi: 10.3390/nu13030785. Nutrients. 2021. PMID: 33673587 Free PMC article. Clinical Trial.
-
Effects of a combination of botanical actives on skin health and antioxidant status in post-menopausal women: A randomized, double-blind, placebo-controlled clinical trial.J Cosmet Dermatol. 2022 May;21(5):2064-2072. doi: 10.1111/jocd.14345. Epub 2021 Jul 21. J Cosmet Dermatol. 2022. PMID: 34260808 Free PMC article. Clinical Trial.
-
Antiosteoporotic Activity of Genistein Aglycone in Postmenopausal Women: Evidence from a Post-Hoc Analysis of a Multicenter Randomized Controlled Trial.Nutrients. 2017 Feb 22;9(2):179. doi: 10.3390/nu9020179. Nutrients. 2017. PMID: 28241420 Free PMC article. Clinical Trial.
Cited by
-
The state of the art in anti-aging: plant-based phytochemicals for skin care.Immun Ageing. 2025 Jan 31;22(1):5. doi: 10.1186/s12979-025-00498-9. Immun Ageing. 2025. PMID: 39891253 Free PMC article. Review.
-
Development and Evaluation of Anti-Pollution Film-Forming Facial Spray Containing Coffee Cherry Pulp Extract.Pharmaceutics. 2025 Mar 12;17(3):360. doi: 10.3390/pharmaceutics17030360. Pharmaceutics. 2025. PMID: 40143024 Free PMC article.
-
Phytoestrogens as Natural Anti-Aging Solutions for Enhanced Collagen Synthesis in Skin.J Cosmet Dermatol. 2025 Feb;24(2):e16719. doi: 10.1111/jocd.16719. Epub 2024 Dec 9. J Cosmet Dermatol. 2025. PMID: 39654355 Free PMC article.
-
Preparation, optimization, and characterization of genistein-ginseng long-acting polymeric gel as a breast cancer treatment alternative.Discov Oncol. 2024 Jul 3;15(1):257. doi: 10.1007/s12672-024-01132-8. Discov Oncol. 2024. PMID: 38960937 Free PMC article.
-
Natural Modulators of Key Signaling Pathways in Skin Inflammageing.Clin Cosmet Investig Dermatol. 2024 Dec 18;17:2967-2988. doi: 10.2147/CCID.S502252. eCollection 2024. Clin Cosmet Investig Dermatol. 2024. PMID: 39712942 Free PMC article. Review.
References
Grants and funding
LinkOut - more resources
Full Text Sources